Marianne De Backer insider trades

Open-market stock purchases and sales by Marianne De Backer, President and CEO at Vir Biotechnology, Inc, from SEC Form 4 filings since Jan 1, 2020.

Track record: 100% of 9 scored buys are up 5% or more since purchase, averaging +164%.

Recent trades

DateStockTradeValue
Apr 29, 2026VIR Vir Biotechnology, IncBought (not open market)—
Apr 6, 2026VIR Vir Biotechnology, IncSold$664K
Feb 24, 2026VIR Vir Biotechnology, IncSold$141K
Feb 23, 2026VIR Vir Biotechnology, IncSold$142K
Feb 22, 2026VIR Vir Biotechnology, IncBought (not open market)—
Feb 22, 2026VIR Vir Biotechnology, IncBought (not open market)—

Companies traded

  • VIR Vir Biotechnology, Inc: 6 sales, last Apr 29, 2026
  • KRON Kronos Bio, Inc: 3 buys, last Jun 22, 2023
  • ARWR Arrowhead Pharmaceuticals, Inc: 9 buys, 4 sales, last Jan 10, 2023

Get free alerts when Marianne De Backer files a new trade →